Cluster 4/5 was treated with the dual ICI regimen of ipilimumab plus nivolumab. This arm remains open to accrual. Clusters 3, 6, and 7 were excluded from the study. Additional secondary endpoints are ...

The Cooper Companies looks set to outperform with strong fundamentals, insider buying, and market leadership in lenses amid ...

With over 1bn TikTok views and scores of products on supermarket shelves, #hothoney is the sweet and spicy flavour of the ...